IndraLab

Statements


USP18 binds IFN-α/β receptor 2 complex. 1 / 1
| 1

reach
"Independent of its deISGylating activity, USP18 also binds to IFN-α/β receptor 2 complex, where it competes with JAK1, thereby negatively regulating type I IFN signaling."